CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 79.01% | -4,668.97% | -42.32% | 59.84% | -19.65% |
| Total Depreciation and Amortization | 0.00% | -2.33% | 1.74% | 1.41% | 1.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 159.78% | 1,249.22% | 100.00% | 384.06% | -335.53% |
| Change in Net Operating Assets | -159.14% | 33.96% | -291.93% | -47.56% | 93.48% |
| Cash from Operations | 82.26% | 206.85% | -38.59% | -7.08% | 170.56% |
| Capital Expenditure | -2.08% | -4.18% | 4.86% | -5.39% | 15.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 30.00% | -2,316.67% | -147.92% | 20.00% | 91.67% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -622.51% | 58.76% | 68.26% | 100.07% | 209.48% |
| Cash from Investing | -265.27% | 37.65% | 36.98% | 63.61% | 55.96% |
| Total Debt Issued | -100.00% | 408.00% | -62.25% | -- | 2,036.50% |
| Total Debt Repaid | 58.69% | -153.17% | 483.56% | -8,800.00% | -609.95% |
| Issuance of Common Stock | 352.63% | 2.63% | 88.00% | -29.06% | -45.71% |
| Repurchase of Common Stock | -225.00% | -400.00% | 19.72% | 99.64% | 20.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.84% | -1.08% | -0.93% | 0.00% | -7.57% |
| Other Financing Activities | -85.42% | 375.00% | -833.33% | 30.30% | 433.33% |
| Cash from Financing | -571.46% | 12.97% | -35.47% | -90.06% | 144.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -136.70% | 52.94% | -38.11% | -7.59% | 135.96% |